MONICA THIELEN: Open Payments
NPI 1770997470 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 80 payments from 15 companies in 2025. Trend: 2023 $1,370 · 2024 $1,965 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $502 |
| Lilly USA, LLC | 4 | $84 |
| Eisai Inc. | 3 | $76 |
| Lundbeck LLC | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Genentech USA, Inc. | 2 | $48 |
| Mallinckrodt Hospital Products Inc. | 2 | $48 |
| Celgene Corporation | 2 | $34 |
| UCB, Inc. | 1 | $22 |
| EMD Serono, Inc. | 1 | $22 |
Products named: QULIPTA, UBRELVY, Leqembi, KISUNLA, VYEPTI, AUSTEDO XR, ACTHAR, ZEPOSIA.
Industry payments across KS — which companies pay providers there.
